As increased ATP13a2 expression was reported to rescue lysosomal dysfunction in Parkinson’s disease fibroblasts [57], we hypothesise that upregulation of ATP13a2 in CLN6 affected sheep may similarly compensate to partially improve lysosomal function. This evidence concerns the gene CLN6 and Parkinson disease.